Cabozantinib-phospholipid complex for enhanced solubility, bioavailability, and reduced toxicity in liver cancer
CBZ-PLS significantly improves the solubility, bioavailability, and therapeutic efficacy of CBZ against liver cancer, presenting a promising approach for more effective liver cancer treatment.
Authors
- Payal Dande (ORCID: https://orcid.org/0000-0003-3384-7454)
- Suprit D. Saoji (ORCID: https://orcid.org/0000-0003-1747-7844)
- Sankha Bhattacharya (ORCID: https://orcid.org/0000-0002-0771-9582)
- Jayesh Patil
Institutions
- Rashtrasant Tukadoji Maharaj Nagpur University (IN)
- Narsee Monjee Institute of Management Studies (IN)
Publication Details
- Journal
- Therapeutic Delivery
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1080/20415990.2024.2435240
- Citations
- 13
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.03